A medicinal product may only be brought onto the market in the Netherlands when it has been granted a marketing authorisation. The MEB assesses a medicinal product on the basis of criteria as stated in the Medicines Act (Gmw) and determines the conditions for its approval onto the Dutch market.

Anyone who uses medicines should be able to trust them. The MEB is dedicated to fulfilling this mission every single day, in the Netherlands and in Europe.

Good medicines used better.


More news